FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

24560411000001103: Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-May 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2110681000001114 Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2110691000001111 Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Is a Fentanyl 25micrograms/hour patch false Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has active ingredient Fentanyl true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has specific active ingredient Fentanyl true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Is a Mylafent true Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Is a Fentanyl 25micrograms/hour transdermal patches false Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Is a Fentanyl 25micrograms/hour transdermal patches true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch Has AMP True Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start